Alain Didier
Elite in Grass Allergy

Alain Didier

Toulouse, FR 
Elite in Grass Allergy
Toulouse, FR 
OverviewLocationsClinical Research

Overview

Alain Didier practices in Toulouse, France. Mr. Didier and is rated as an Elite expert by MediFind in the treatment of Grass Allergy. His top areas of expertise are Grass Allergy, Asthma, Giant Papillary Conjunctivitis, Endoscopy, and Lung Transplant.

His clinical research consists of co-authoring 159 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Grass Allergy.

Gender
Male

Locations

Toulouse, 31059, France
Other Locations
Pointe À-pitre, France
Bordeaux, France
66, Boulevard Saint Michel, Paris, 75006, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Chronic Cough and Small Fiber Neuropathy
Chronic Cough and Small Fiber Neuropathy
Enrollment Status: Terminated
Publish Date: October 23, 2024
Intervention Type: Other
Study Phase: Not Applicable
High Flow Oxygen (HFO) VERSUS Non Invasive Ventilation (NIV) Associated to Automated Flow Oxygen Titration (AFOT) After Extubation in Patient With Respiratory Risk: Non-inferiority Prospective Comparative Study
High Flow Oxygen (HFO) VERSUS Non Invasive Ventilation (NIV) Associated to Automated Flow Oxygen Titration (AFOT) After Extubation in Patient With Respiratory Risk: Non-inferiority Prospective Comparative Study
Enrollment Status: Completed
Publish Date: November 10, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

159 Total Publications

Long-term effectiveness and safety of dupilumab in severe asthma: a 5-year real-world multicenter study.
Long-term effectiveness and safety of dupilumab in severe asthma: a 5-year real-world multicenter study.
Journal: The journal of allergy and clinical immunology. In practice
Published: January 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Didier's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile